ACAD - ACADIA Pharmace Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 UGAZ (%) TVIX (%) TPR (%) SPY (%) SMH (%) RETA (57.48%) ONCS (-1.88%) OKTA (0.32%) NVDA (5.46%) NTRP (%) LULU (%) JPM (%) IWM (%) ICLN (-1%) HPQ (%) GSKY (%) GS (%) GOGO (%) FUNC (%) FDX (%) ESNT (2.8%) DVN (%) DLR (%) DGAZ (-2.82%) BBBY (%)

ACAD - ACADIA Pharmaceutica...

$39.94 0.46[1.16%]

15 mins delayed data

People also watch : LLY | VNDA | JNJ | BMY | PFE | ADMS

+Watchlist

4 StockHoot Traders following this.
Analyst Ratings | Earnings

Biotech Stock Roundup: GILD's Descov...	10/09/19
Key highlights of the past week include label expansion of drugs, licensing deals and more.

Acadia Sees Strong Results in Dementia T...	10/08/19
Phase III HARMONY trial conducted by Acadia Pharmaceuticals (ACAD) recently delivered robust statistically superior data (p=0.0033) compared to placeb...

ACADIA Pharmaceuticals Presents Addition...	10/07/19
— Pimavanserin as adjunctive treatment to SSRI/SNRI therapies significantly improved sexual dysfunction symptoms compared to placebo in MDD patients

ACADIA Pharmaceuticals Announces Late-Br...	10/03/19
ACADIA Pharmaceuticals Inc. today announced that the presentation of the results from the Phase 3 HARMONY study of pimavanserin in dementia-related ps...

We Think ACADIA Pharmaceuticals (NASDAQ:...	10/02/19
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Should First Trust Mid Cap Growth AlphaD...	09/26/19
Style Box ETF report for FNY

Strong Buy rating	10/01/19
RBC Capital initiates coverage with Outperform rating and announces Price Target of $60.00

Strong Buy rating	09/23/19
Cantor Fitzgerald maintains Overweight rating and raises Price Target from $49.00 to $56.00

Strong Buy rating	09/13/19
SVB Leerink upgrades from Market Perform to Outperform rating and raises Price Target from $21.00 to $50.00

Buy rating	09/09/19
Needham maintains Buy rating and raises Price Target from $34.00 to $60.00

Hold rating	09/03/19
Stifel Nicolaus maintains Hold rating and raises Price Target from $24.00 to $28.00

Strong Buy rating	08/27/19
and raises Price Target from $30.00 to $40.00

HOLDERS

% Insider	12.52%	% Institutional	76.43%

Top 10 Institutional Owners

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%

Previous Close	$39.48	Open	$39.57
Volume	873K	Market Cap	3.583B
Yield		Last Dividend

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Service Name	Trader	% Success
Big Data Kornacki & Zhou	Zhou Academy	88.00 %	Subscribe
Arbitrage Trade Analytics	Royce Wells	72.00 %	Subscribe
Alpha Swing Trades	Jonathan	69.00 %	Follow
Best Trading Ideas	Best Trading Ideas	53.00 %	Follow

ACAD - ACADIA Pharmaceutica...

$39.94 0.46[1.16%]

Add to New List:

Day

52 Week

ANALYST RATINGS

83.33 %

Price Target (PT)

EARNINGS

FINANCE

HOLDERS

Top 10 Institutional Owners

TRADERS TRACKING $ACAD

About Us

Product Types

Strategies

Follow Us

Secure Payments